LINCOLNSHIRE, Ill.—Flexan L.L.C. continues to add valuable pieces to its medical operations, as it recently acquired IntroMed L.L.C., a manufacturer of patented sheath introducers used in catheter placements.
Based in Salt Lake City, IntroMed operates out of a 6,000-sq.-ft. operation with 25 employees. The firm utilizes polyurethane, high performance plastics and acrylic polymers to produce its parts.
Financial details were not disclosed. Flexan CEO Jim Fitzgerald said the unique technology was just one part of IntroMed's appeal.
"What we really saw in IntroMed was the alignment with our focus of being an engineering partner of any customer in any space that's trying to solve a technical problem, leveraging our knowledge of how to work in the polymer category to create a sub-assembly or finished device that will deliver some value in the market," Fitzgerald said.
"While we now have this one particular patented sheath, more broadly it's another example of collaborating with your customers to put more innovative products out on the market that allows them to gain additional market share."
IntroMed sources its extruded products and performs the secondary operations—overmolding, tipping, boding and printing—in-house. Flexan will allow IntroMed to source those extrusions internally through its expanding thermoplastic extrusion capabilities.